XAIR (AINostix) הכנסות חזויות של החברה

Beyond Air, Inc. (XAIR) generates revenue through the sale of advanced nitric oxide synthesis systems for clinical and private use. The projected future sales indicator on the GURU.Markets terminal chart reflects revenue dynamics, where the value has stabilized at 0.01. The LungFit product addresses the lung therapy market, including neonatal care, while optimized logistics with buffer stocks completely mitigate the risk of supply chain disruptions.
פילוחים אנליטיים ודוחות נתונים של חברת Beyond Air, Inc. (XAIR)

The scale of operations at Beyond Air, Inc. correlates directly with the expansion of innovative medical systems. By analyzing the company's planned sales volume, investors assess the expected cash flow from future contracts. This metric measures capitalization potential through revenue forecasts, reflecting market expectations for product commercialization. For XAIR, this indicator depends on the pace of FDA approvals and the deployment of equipment in clinics. The trend of the curve confirms the fundamental stability of the business.